These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21438068

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
    Mona Eng P, Seeger JD, Loughlin J, Oh K, Walker AM.
    Contraception; 2007 Feb; 75(2):101-7. PubMed ID: 17241838
    [Abstract] [Full Text] [Related]

  • 24. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 25. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG, Mioduch HJ.
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H, Vanholder R, Billiouw JM, Lameire N.
    Am J Med; 2001 Apr 15; 110(6):438-41. PubMed ID: 11331054
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients.
    Lin HH, Yang YF, Chang JK, Ting IW, Kuo HL, Wang IK, Huang CC.
    Ren Fail; 2009 Apr 15; 31(10):942-5. PubMed ID: 20030530
    [Abstract] [Full Text] [Related]

  • 30. Adverse biochemical and clinical consequences of furosemide administration.
    Spino M, Sellers EM, Kaplan HL, Stapleton C, MacLeod SM.
    Can Med Assoc J; 1978 Jun 24; 118(12):1513-8. PubMed ID: 657047
    [Abstract] [Full Text] [Related]

  • 31. Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination: a population-based analysis.
    Besançon JF, Lagarce L, Diquet B, Lainé-Cessac P.
    Pharmacoepidemiol Drug Saf; 2008 Feb 24; 17(2):172-9. PubMed ID: 17948926
    [Abstract] [Full Text] [Related]

  • 32. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I, Yalcin S, Ozhan H.
    Kardiol Pol; 2010 Sep 24; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs.
    Berkova M, Berka Z, Topinkova E.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep 24; 158(1):84-91. PubMed ID: 23128820
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Factors predicting hyperkalemia in patients with cirrhosis receiving spironolactone.
    Abbas Z, Mumtaz K, Salam A, Jafri W.
    J Coll Physicians Surg Pak; 2003 Jul 24; 13(7):382-4. PubMed ID: 12887837
    [Abstract] [Full Text] [Related]

  • 39. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation.
    Xia VW, Ghobrial RM, Du B, Chen T, Hu KQ, Hiatt JR, Busuttil RW, Steadman RH.
    Anesth Analg; 2007 Sep 24; 105(3):780-5. PubMed ID: 17717240
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.